Don't think they have yet, they'd need to get the data peer reviewed first before they begin going through the FDA approval process for closed angle glaucoma. However the preliminary data they've presented at conferences looks very impressive, and is probably why it has become quite core topic at recent conferences for Nova Eye Medical. They'd probably take the 510(K) route which will mean it should be quickly approved when the data is ready.
This is an announcement from late last year, if they can get it approved quick that's an extra 30 million patients who currently have very limited treatment options (zero MIGS options), and are at a much higher risk of blindness than open angle glaucoma patients.
- Forums
- ASX - By Stock
- Nova Eye Medical (EYE) Discussion
Don't think they have yet, they'd need to get the data...
-
-
- There are more pages in this discussion • 384 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $56.06M |
Open | High | Low | Value | Volume |
24.0¢ | 24.8¢ | 24.0¢ | $37.68K | 153.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 150677 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 77366 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 150677 | 0.240 |
3 | 347553 | 0.235 |
2 | 93400 | 0.230 |
3 | 21000 | 0.225 |
8 | 236721 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 77366 | 4 |
0.255 | 28307 | 2 |
0.265 | 65000 | 2 |
0.270 | 29308 | 3 |
0.275 | 104200 | 2 |
Last trade - 12.13pm 30/07/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online